Success Stories: NIW Approval Received in Just 2 Months and 20 Days for an Indian Assay Development Scientist in Molecular Biology, Credit Goes to Our Team of Experts

 

Client’s Testimonial:

“Thank you for all your help.”


On April 21st, 2022, we received another EB-2 NIW (National Interest Waiver) approval for an Assay Development Scientist in the Field of Molecular Biology (Approval Notice).


General Field: Molecular Biology

Position at the Time of Case Filing: Assay Development Scientist

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: April 21st, 2022

Processing Time: 2 months, 20 days


Case Summary:

The EB2-NIW (National Interest Waiver) is a kind of nonimmigrant visa for those foreign nationals who can show that their work is of value to the United States. This means that successful candidates would be granted a continuance of research work here in the United States without an actual job offer or labor certification. So when NAILG got a request from an assay development scientist, to file his NIW petition, we made sure that he had everything needed to win the case. We ended up collecting the following data for his petition packet:

  • As an expert in the field of molecular biology, his proposed endeavor is to continue his research on the application of immunological and point-of-care-based assays to develop low-cost tools for diagnosing infectious diseases in order to mitigate the public health impact of infectious diseases.
  • His research related to developing low-cost tools for diagnosing infectious diseases in order to address the public health challenges related to infectious diseases has great substantial merit and national importance.
  • He has also completed at least 20 reviews to date which shows that he is considered a reliable expert in the field.
  • His research has also resulted in 14 peer-reviewed journal articles (6 of them first-authored).
  • Not only this, but his research has also gone on to influence his peers. That is, his publications have been cited a total of 249 times according to Google Scholar.
  • He has pursued research directly related to his proposed endeavor of developing low-cost tools for diagnosing infectious diseases in order to mitigate their public health impact for 11 years.
  • His work was also supported by 2 other experts through letters of recommendation.
So, when his approval came through, we were proud of having worked for him. We were also glad to know that he did not get an RFE and his approval came through in just 2 months and 20 days. We wish him all the best in his future endeavors.